Phase XI, gr 2 01.07.2012 - 30.06.2015

Ca.-No 150

The DNA methylation program in inflammation cancer

Israeli Partner: Y. Bergman, Hebrew University
German Partner: F. Lyko, DKFZ

Ca.-No 151

Modulation of regulatory T cell function by novel Treg-specific monoclonal antibodies

Israeli Partner: J. Abramson, Weizmann Institute of Science
German Partner: M. Feuerer, DKFZ

Publications

2015 - Cancer Res, 75 (10): p. 2120-30

Ca.-No 152

Characterizing the role of the microenvironment in facilitating melanoma brain metastasis

Israeli Partner: N. Erez, Tel Aviv University
German Partner: K. Mueller-Decker, DKFZ

Publications

2015 - Prog Mol Biol Transl Sci, 136: p. 175-205
2015 - J Immunol, 195 (5): p. 2067-79
2015 - J Immunol, 195 (7): p. 3058-70
2015 - PLoS One, 10 (5): p. e0127038

Ca.-No 153

microRNA control of MSC and CAF in breast cancer: A proangiogenic switch and cell-remodeling

Israeli Partner: A. Ben-Baruch, Tel Aviv University
German Partner: S. Wiemann, DKFZ

Publications

2015 - J Pathol, 236 (1): p. 116-27
2016 - Cancer Res, 76 (15): p. 4359-71

Ca.-No 154

Impact of the pro-inflammatory microenvironment on cellular programs of oncogene induced senescence during carcinogenesis

Israeli Partner: V. Krizhanovsky, Weizmann Institute of Science
German Partner: J. Hess, DKFZ

Publications

2016 - J Leukoc Biol, 99 (6): p. 1009-25
2017 - Oncotarget, 8 (27): p. 43897-43914
2017 - Front Immunol, 8: p. 479

Publications

2015 - Genes Dev, 29 (8): p. 791-802
2015 - Cancer Lett, 358 (2): p. 191-9
Formular

Formulardaten werden geladen ...